Article
Hepatitis C Virus-Escape Studies for Human Monoclonal Antibody AR4A Reveal Isolate-Specific Resistance and a High Barrier to Resistance.
The Journal of infectious diseases - 1 Jan 2019
Velázquez-Moctezuma Rodrigo, Galli Andrea, Law Mansun, Bukh Jens, Prentoe Jannick
Abstract excerpt
Global control of hepatitis C virus (HCV) depends on development of a prophylactic vaccine. We studied escape for cross-genotype-reactive neutralizing antibody AR4A, providing valuable information for HCV vaccine design. We cultured HCV core-NS2 recombinants H77 (genotype 1a)/JFH1 or the highly antibody-susceptible hypervariable region 1 (HVR1)-deleted variants H77/JFH1∆HVR1 and J6(genotype 2a)/JFH1∆HVR1 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
